SCHOOL OF MEDICINE
|
HEALTH SCIENCES
|
HSLS
|
FIND PEOPLE AT PITT
Home
About
Directory
Research Information
Blog
Graduate Program
Event Calendar
Links
Contact
Department Only
Mission and History
Department Statistics
Annual Report
Building Information
Thomas E. Starzl BST
Biomedical Science Tower 3
Faculty
Graduate Students
Fellows
Administrative Staff
Research Staff
Research Areas
Labs
Equipment
Funding Opportunities
Summer Fellowships
Faculty Development Program
Blog Archive
PORtal
Equipment/IT Support Request
Poster Requests
Web Calendars
Teleconferencing Request
(pharmacology.us site search is temporarily unavailable)
Peter A. Friedman, PhD
Professor & Vice Chair, Academics
E1356 Biomedical Science Tower
200 Lothrop Street, Pittsburgh, PA 15261
Email:
paf10@pitt.edu
Phone:
412-383-7783
Fax:
412-648-1945
Education
BA (Zoology), Syracuse University, 1970.
PhD (Pharmacology), SUNY Upstate Medical Center, 1975.
Postdoctoral Fellow (Pharmacology), University of Lausanne, Switzerland, 1975-1977.
Postdoctoral Fellow (Physiology), Cornell University Medical College, 1977-1979.
Research Areas
Receptor Pharmacology
Signal Transduction
Important Publications
Friedman Lab
PubMed Information
NIH RePORTER
Studies in my laboratory focus on spatiotemporal regulation of protein-protein interactions governing GPCR signaling and function. We are especially interested in the parathyroid hormone receptor (PTHR), which controls extracellular mineral ion homeostasis and bone turnover. Key advances have been made in understanding cell-specific PTHR signaling, trafficking, and post-translational modifications. Recent observations indicate that PTHR activation, desensitization and endocytosis are mediated through distinct structural states that derive from specific interactions between ligand andreceptor. Agonist- or antagonist-occupied receptor states induce discrete conformations with accessibility to intracellular receptor domains. The differential or inducible involvement of these domains in coupling to G proteins may represent a molecular basis for ligand-selective responses notonly for the PTHR, but also for other G protein-coupled receptors, and are novel drug targets. Current work is directed at elucidating the molecular and structural mechanisms of how cytoplasmic PDZ proteins such as NHERF1 legislate cell-, ligand-, and stage-specific receptor trafficking. The resulting information will be valuable in understanding mineral ion homeostasis under normal conditions, as well as disordered calcium balance in renal failure, hyperparathyroidism, or osteoporosis.
Important Publications
Alonso V and
PA Friedman
. Ubiquitination-regulated G protein-coupled receptor signaling and trafficking. Mol Endocrinol 27:558-572, 2013.
Wang B, Y Yang, L Liu, HC Blair and
PA Friedman
. NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts. Bone 52:268-277, 2013.
Wang B, CK Means, Y Yang, T Mamonova, A Bisello, DL Altschuler, JD Scott and
PA Friedman
. Ezrin-anchored PKA coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport. J Biol Chem doi:10.1074/jbc M112.369405, 2012.
Liu L, V Alonso, L Guo, I Tourkova, SE Henderson, AJ Almarza,
PA Friedman
and HC Blair. Na
+
/H
+
-exchanger regulatory factor-1 (NHERF1) directly regulates osteogenesis. J Biol Chem 287:43312-43321, 2012.
Mamonova T, M Kurnikova and
PA Friedman
. Structural basis for NHERF1 PDZ domain binding affinity. Biochemistry 51:3110-3120, 2012.
Back to Top